全文获取类型
收费全文 | 923篇 |
免费 | 58篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 38篇 |
妇产科学 | 37篇 |
基础医学 | 149篇 |
口腔科学 | 83篇 |
临床医学 | 42篇 |
内科学 | 168篇 |
皮肤病学 | 14篇 |
神经病学 | 7篇 |
特种医学 | 6篇 |
外科学 | 37篇 |
综合类 | 101篇 |
预防医学 | 206篇 |
眼科学 | 1篇 |
药学 | 116篇 |
1篇 | |
中国医学 | 15篇 |
肿瘤学 | 16篇 |
出版年
2024年 | 2篇 |
2023年 | 12篇 |
2022年 | 35篇 |
2021年 | 68篇 |
2020年 | 53篇 |
2019年 | 31篇 |
2018年 | 30篇 |
2017年 | 34篇 |
2016年 | 48篇 |
2015年 | 37篇 |
2014年 | 62篇 |
2013年 | 112篇 |
2012年 | 62篇 |
2011年 | 63篇 |
2010年 | 54篇 |
2009年 | 48篇 |
2008年 | 54篇 |
2007年 | 45篇 |
2006年 | 36篇 |
2005年 | 36篇 |
2004年 | 19篇 |
2003年 | 16篇 |
2002年 | 25篇 |
2001年 | 3篇 |
2000年 | 2篇 |
1999年 | 15篇 |
1998年 | 5篇 |
1997年 | 4篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 3篇 |
1993年 | 4篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有1038条查询结果,搜索用时 15 毫秒
31.
Agata Kujawa-Szewieczek Marcin Adamczak Katarzyna Kwiecień Sylwia Dudzicz Magdalena Gazda Andrzej Wi?cek 《Nutrients》2015,7(12):10179-10188
Background:
Lactobacillus plantarum 299v (LP299v) has been used in order to reduce gastrointestinal symptoms during antibiotic exposure. However, it remains controversial whether or not probiotics are effective in the prevention of Clostridium difficile infections (CDI) among patients receiving antibiotics. The aim of this study was to analyze the CDI among patients receiving antibiotics and hospitalized in the period before and after starting routine use of LP299v as a prevention of this infection. Methods: Among 3533 patients hospitalized in the nephrology and transplantation ward during a two-year period, 23 patients with CDI were diagnosed and enrolled in this retrospective study. Since November 2013, prevention of CDI with oral use of LP299v was performed in all patients treated with antibiotics and who were at a high risk of developing CDI. The observation period was divided into two twelve-month intervals before and after initiation of the use of LP299v as a prophylactic against CDI. Results: A significant (p = 0.0001) reduction of the number of cases of CDI was found after routinely using LP299v (n = 2; 0.11% of all hospitalized patients) compared with the previous twelve-month period of observation (n = 21; 1.21% of all hospitalized patients). Conclusions: Routine use of LP299v during treatment with antibiotics may prevent C. difficile infection in the nephrology and transplantation ward. 相似文献
32.
Brianna Lindsay Joe Oundo M. Anowar Hossain Martin Antonio Boubou Tamboura Alan W. Walker Joseph N. Paulson Julian Parkhill Richard Omore Abu S.G. Faruque Suman Kumar Das Usman N. Ikumapayi Mitchell Adeyemi Doh Sanogo Debasish Saha Samba Sow Tamer H. Farag Dilruba Nasrin Shan Li Sandra Panchalingam Myron M. Levine Karen Kotloff Laurence S. Magder Laura Hungerford Halvor Sommerfelt Mihai Pop James P. Nataro O. Colin Stine 《Emerging infectious diseases》2015,21(2):242-250
Pathogens in the gastrointestinal tract exist within a vast population of microbes. We examined associations between pathogens and composition of gut microbiota as they relate to Shigella spp./enteroinvasive Escherichia coli infection. We analyzed 3,035 stool specimens (1,735 nondiarrheal and 1,300 moderate-to-severe diarrheal) from the Global Enteric Multicenter Study for 9 enteropathogens. Diarrheal specimens had a higher number of enteropathogens (diarrheal mean 1.4, nondiarrheal mean 0.95; p<0.0001). Rotavirus showed a negative association with Shigella spp. in cases of diarrhea (odds ratio 0.31, 95% CI 0.17–0.55) and had a large combined effect on moderate-to-severe diarrhea (odds ratio 29, 95% CI 3.8–220). In 4 Lactobacillus taxa identified by 16S rRNA gene sequencing, the association between pathogen and disease was decreased, which is consistent with the possibility that Lactobacillus spp. are protective against Shigella spp.–induced diarrhea. Bacterial diversity of gut microbiota was associated with diarrhea status, not high levels of the Shigella spp. ipaH gene. 相似文献
33.
目的:观察米氮平联合奥替溴铵及复合乳酸菌胶囊治疗难治性腹泻型肠易激综合征(RIBS-D)的临床疗效。方法:82例RIBS-D患者随机分为试验组(43例)与对照组(39例),两组均给奥替溴铵及复合乳酸菌胶囊,试验组加服米氮平,对照组加服安慰剂,疗程4周。结果:试验组与对照组的总有效率分别为95.35%、12.82%(P<0.01);试验组焦虑及抑郁评分较对照组显著降低,生活质量评分较对照组显著升高,差异均有统计学意义(P<0.01)。结论:米氮平联合奥替溴铵及复合乳酸菌胶囊治疗RIBS-D患者,能明显改善症状、焦虑抑郁状态及生活质量,十分安全。 相似文献
34.
Lactobacillus plantarum 299v Inhibits Escherichia coli-Induced Intestinal Permeability 总被引:1,自引:0,他引:1
Mangell P Nejdfors P Wang M Ahrné S Weström B Thorlacius H Jeppsson B 《Digestive diseases and sciences》2002,47(3):511-516
The purpose of this work was to investigate whether a probiotic bacterium, Lactobacillus plantarum 299v, could affect Escherichia coli-induced passage of mannitol across the intestinal wall. Sprague-Dawley rats were pretreated for one week by either tube feeding with L. plantarum 299v twice daily, free access to L. plantarum 299v by adding the bacterium in the drinking water, or negative control receiving regular feeding. Intestinal segments were mounted in Ussing chambers and the mucosa was exposed to control medium, E. coli, and L. plantarum 299v (alone or together). [14C]Mannitol was added as a marker of intestinal permeability and samples were taken from the serosal side. E. coli exposure induced a 53% increase in mannitol passage across the intestinal wall (P < 0.05). One week of pretreatment with L. plantarum 299v in the drinking water abolished the E. coli-induced increase in permeability. Tube feeding for one week or short-term addition of L. plantarum 299v in the Ussing chambers had no effect on the permeability provoked by E. coli challenge. Notably, L. plantarum 299v itself did not change the intestinal passage of mannitol. These data demonstrate that pretreatment with L. plantarum 299v, which is a probiotic bacterium, protects against E. coli-induced increase in intestinal permeability, and that L. plantarum 299v alone has no influence on the intestinal permeability. Thus, this study supports the concept that probiotics may exert beneficial effects in the gastrointestinal tract. 相似文献
35.
36.
幽门螺杆菌(Hp)感染与慢性胃炎、消化性溃疡、胃黏膜相关淋巴样组织淋巴瘤和胃癌等疾病的发生有关。有研究显示,联合使用嗜酸乳杆菌能提高Hp根除率,并降低治疗过程中的不良反应。目的:探讨复方嗜酸乳杆菌片联合含铋剂四联疗法对首次根除失败的Hp感染的疗效。方法:将180例经标准三联疗法首次根除失败的Hp阳性的消化性溃疡患者随机分为试验组和对照组,试验组患者给予复方嗜酸乳杆菌片1 g tid,餐后服用,疗程14 d,然后给予雷贝拉唑10 mg bid+阿莫西林1 000 mg bid+呋喃唑酮100 mg bid+枸橼酸铋钾300 mg qid,疗程10 d。对照组患者给予雷贝拉唑10 mg bid+阿莫西林1 000 mg bid+呋喃唑酮100 mg bid+枸橼酸铋钾300 mg qid,疗程10 d。治疗结束至少4周后行~(13)C-尿素呼气试验,评估Hp根除率和不良反应。结果:试验组PP根除率和ITT根除率与对照组相比均无明显差异(PP:81.2%对78.2%,χ~2=0.241,P=0.623;ITT:76.7%对75.6%,χ~2=0.031,P=0.861)。试验组恶心呕吐(2.4%对11.5%)、腹泻(0对9.2%)的发生率明显低于对照组(P0.05)。结论:复方嗜酸乳杆菌片联合含铋剂四联疗法对首次标准三联疗法根除失败的Hp患者疗效较好,同时可有效减少不良反应。 相似文献
37.
38.
幽门螺杆菌(Helicobacter pylori,H.pylori)感染与上胃肠道疾病密切相关。由于H.pylori对抗生素耐药率的增加及根除治疗过程中不良反应的出现,导致标准三联疗法H.pylori根除率逐渐下降。益生菌辅助治疗H.pylori感染已取得一些成果,其在提高H.pylori根除率、降低不良反应中的作用日益受到重视。在H.pylori根除治疗中何时加用益生菌、加用何种益生菌成为国内外研究的热点,益生菌的疗效很大程度上依赖于菌种或菌株类型。益生菌还具有维持胃肠道微生态的稳定、减轻黏膜炎症反应等多种作用,本文对益生菌在根除H.pylori治疗中的作用机制及临床意义、益生菌在降低H.pylori治疗相关不良反应中的作用作一概述。 相似文献
39.
乳杆菌是大多数健康女性阴道微生态中的优势菌群,对预防泌尿生殖系统感染性疾病起重要作用。能产生乳酸、过氧化氢、细菌素和生物表面活性物质等抑菌物质是乳杆菌成为潜在益生菌的重要基础。本文对阴道来源的乳杆菌抑菌物质相关研究进展作一综述。 相似文献
40.
目的研究嗜酸乳杆菌对人舌癌细胞Tca8113增殖及细胞周期的影响。方法体外培养Tca8113细胞,分别将不同稀释度(原液和4、16倍稀释)的嗜酸乳杆菌上清液、灭活菌液和无细胞提取物与Tca8113细胞共培养,采用倒置显微镜观察细胞形态并行细胞计数,磺酰罗丹明B(SRB)法测定细胞增殖率,流式细胞术分析嗜酸乳杆菌各组分对Tca8113细胞增殖及细胞周期的影响,激光扫描共聚焦显微镜(CLSM)检测细胞内自由基和Ca2+含量。结果嗜酸乳杆菌各组分作用于Tca8113细胞48 h后,在倒置显微镜下观察,细胞由菱形、多角形、铺路石状变为细长形。细胞计数与SRB实验分析:在不同稀释度同一培养时间与不同培养时间同一稀释度培养条件下,嗜酸乳杆菌各组分均可明显抑制Tca8113细胞增殖,抑制力随稀释度增加而降低,随培养时间延长而增强。流式细胞术分析:嗜酸乳杆菌各组分作用Tca8113细胞48 h后,细胞增殖指数降低(P<0.01)。CLSM检测:嗜酸乳杆菌各组分作用Tca8113细胞48 h后细胞内自由基和Ca2+含量均升高(P<0.01)。结论嗜酸乳杆菌代谢产物、灭活菌液、无细胞提取物均可抑制Tca8113细胞增殖,可能与菌体及其代谢产物引起细胞内自由基含量增多、Ca2+超载有关。 相似文献